HeartSciences (HSCS) Revenue (2021 - 2025)

HeartSciences (HSCS) has reported Revenue for 5 consecutive years, with $2419.0 the latest figure, recorded in Q4 2025.

• Quarterly Revenue changed N/A year-over-year to $2419.0 in Q4 2025, while the trailing twelve-month figure through Apr 2026 was $8669.0 (down 54.49% YoY) and the FY2026 annual result came in at $4319.0, down 0.71% from the prior year.
• Revenue rose to $2419.0 in Q4 2025 per HSCS's latest filing, from $1900.0 in the prior quarter.
• Over the last five years, Revenue for HSCS reached as high as $14700.0 in Q1 2024 and fell as low as $1900.0 in Q3 2025.
• A 5-year average of $4679.2 and a median of $3550.0 in 2022 frame the typical range for Revenue.
• Annual changes were most pronounced in 2022 — Revenue sank 57.24% — and 2024, when it soared 653.85%.
• Year by year, Revenue stood at $7484.0 in 2021, then plunged by 57.24% to $3200.0 in 2022, then rose by 21.88% to $3900.0 in 2023, then soared by 276.92% to $14700.0 in 2024, then tumbled by 83.54% to $2419.0 in 2025.
• According to Business Quant data, Revenue over the past three periods registered $2419.0, $1900.0, and $4350.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.